Vertex Pharmaceuticals (Nasdaq: VRTX) announced today a reimbursement agreement with NHS England for eligible sickle cell disease (SCD) patients to access the CRISPR/Cas9 gene-edited therapy, CASGEVY® ...

We recently compiled a list of the Jim Cramer Shed Light on These 9 Stocks. In this article, we are going to take a look at ...

Report with the AI impact on market trends - The global biotech market size is estimated to grow by USD 805.6 billion from ...

President Trump signed an executive order on the day of his inauguration that created doubts about the future of a program to ...

Below, check out the roundup of California Healthline's coverage. For today's national health news, read KFF Health News' Morning Briefing.

(Reuters) - Wall Street's main indexes were set to open higher on Friday on gains in Apple following its strong sales ...

Takeda CEO Christophe Weber announced he will step down in 2026 and be replaced by Julie Kim, president of Takeda’s U.S.

U.S. stock index futures rose on Friday after Apple forecast strong sales growth, while investors awaited key inflation data that could influence the Federal Reserve's policy decisions.

The FDA approves a new type of nonopioid painkiller for acute pain. And NBC News speaks to transgender service members who ...

A trained pharmaceutical chemist, Lilly was an archetype of the dynamic and multi-talented 19th century American industrialist, who after his military career ... firms such as Vertex have added ...

Cigna To Reform Prior Authorization, Provider Services In 2025 The Cigna Group will spend up to $150 million to reform its prior authorization, patient advocacy and provider services this year, CEO ...

Federal officials on Thursday approved a new type of pain pill designed to eliminate the risks of addiction and overdose ...